Thymosin Alpha-1 (5mg/10mg)
Immune System Commander
Order Thymosin Alpha-1 (5mg/10mg) online for laboratory research. Compare the listed vial options and current price, then add your selection to cart and continue to checkout. Review available COA records for the exact product, strength and lot. Research Use Only; not for human or veterinary use.
Thymosin Alpha-1 is listed for immune laboratory research. Catalog vial contents are 5mg / 10mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Research Applications & Benefits
- Approved in 35+ countries
- T-cell maturation
- NK cell activation
- Decades of evidence
What is Thymosin Alpha-1?
Approved pharmaceutical in 35+ countries. Enhances T-cell maturation, NK cells, and dendritic cells.
Listed vial contents: 5mg / 10mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
What mechanisms are being studied?
Thymosin Alpha-1 is a 28-amino acid peptide originally isolated from thymic tissue. It activates toll-like receptors (TLR-2 and TLR-9) on dendritic cells, promoting T-cell maturation, differentiation, and function. It enhances NK cell cytotoxicity, increases MHC class I expression, and bridges innate and adaptive immunity.
What are the research questions?
- Hepatitis B and C: Approved as Zadaxin® in 35+ countries for chronic hepatitis treatment.
- Cancer immunotherapy adjunct: Used alongside chemotherapy and immunotherapy to enhance immune function. Studied in melanoma, hepatocellular carcinoma, and NSCLC.
- Vaccine enhancement: Improves vaccine response in immunocompromised populations (elderly, HIV, transplant recipients).
- COVID-19 and viral infections: Significantly reduced mortality in critically ill COVID-19 patients.
- Immune aging (immunosenescence): Restores declining T-cell function associated with aging.
What does the published work describe?
Garaci E et al. (Int J Immunopharmacol 2000) — Comprehensive review. Approved as Zadaxin® in 35+ countries. COVID-19: Wu M et al. — Significantly reduced mortality in critically ill patients. Maio M et al. — Improved survival in melanoma when combined with dacarbazine + IFN-alpha.
What are the limits of this evidence?
The research described concerns the cited experimental materials and models, not proof that this supplied vial is a treatment. Cell or animal findings do not establish human benefits. Clinical findings, where cited, apply to the tested formulation and population; they do not validate this research product for human use.
Study references
- Garaci E et al. Int J Immunopharmacol 2000
These are the catalog's existing bibliographic references. No new source verification is implied by this presentation.
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is Thymosin Alpha-1 handled in the lab?
For Thymosin Alpha-1, record the product code TA1, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
Choose a solvent for Thymosin Alpha-1 from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
For Thymosin Alpha-1, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 3108.27 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
Use the documented storage conditions for the supplied Thymosin Alpha-1 form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A Thymosin Alpha-1 laboratory protocol should record identity, product code TA1, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- Thymosin Alpha-1
- CAS Number
- 62304-98-7
- Molecular Weight
- 3108.27 g/mol
- HPLC Purity Specification
- ≥99%
- Category
- Immune
- Starting Price
- $59.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Thymosin Alpha-1 has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
Frequently Asked Questions
What is Thymosin Alpha-1?
Thymosin Alpha-1 is listed for immune laboratory research. Catalog vial contents are 5mg / 10mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of Thymosin Alpha-1 are available?
The catalog lists 5mg / 10mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret Thymosin Alpha-1 purity results?
Thymosin Alpha-1 has a catalog purity specification of ≥99%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
How should Thymosin Alpha-1 be handled in the laboratory?
For Thymosin Alpha-1, record the product code TA1, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for Thymosin Alpha-1?
Choose a solvent for Thymosin Alpha-1 from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay.
How do I calculate a Thymosin Alpha-1 stock concentration?
For Thymosin Alpha-1, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 3108.27 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
How should Thymosin Alpha-1 be stored after preparation?
Use the documented storage conditions for the supplied Thymosin Alpha-1 form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a Thymosin Alpha-1 lab protocol document?
A Thymosin Alpha-1 laboratory protocol should record identity, product code TA1, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this Thymosin Alpha-1 product?
Fmoc and Boc are peptide protecting-group strategies, not proof of how this Thymosin Alpha-1 lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.
Is Thymosin Alpha-1 for human use?
No. Thymosin Alpha-1 is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
